Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imaging local brain function with emission computed tomography.

D E Kuhl

    Radiology
    |March 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Novel insertional presenilin 1 mutation causing Alzheimer disease with spastic paraparesis.

    Neurology·2004
    Same author

    Dual-[11C]tracer single-acquisition positron emission tomography studies.

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2001
    Same author

    Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation.

    Annals of neurology·2001
    Same author

    Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.

    Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2001
    Same author

    Radiolabeled cholinesterase substrates: in vitro methods for determining structure-activity relationships and identification of a positron emission tomography radiopharmaceutical for in vivo measurement of butyrylcholinesterase activity.

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism·2001
    Same author

    Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET.

    Synapse (New York, N.Y.)·2001
    Same journal

    Erratum for: Prediction of Lobar Emphysema Progression with a CT-Based Foundational Model.

    Radiology·2026
    Same journal

    Erratum for: Associations of MRI-derived Paraspinal IMAT and LMM with Cardiometabolic Risk Factors: Results from a German Cohort.

    Radiology·2026
    Same journal

    Erratum for: Blue Rubber Bleb Nevus Syndrome.

    Radiology·2026
    Same journal

    Redefining the Clinical Role of MRI in Endometrial Cancer Staging.

    Radiology·2026
    Same journal

    To Ablate or Not to Ablate: The Colorectal Liver Metastasis Question.

    Radiology·2026
    Same journal

    The Limits of Radiologic Categorization in Pulmonary Nonsolid Nodules.

    Radiology·2026
    See all related articles

    Positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) reveals brain metabolic patterns, offering insights beyond structural imaging. This technique aids in diagnosing neurological conditions like stroke, dementia, and epilepsy by mapping glucose utilization.

    Area of Science:

    • Neuroscience
    • Nuclear Medicine
    • Radiology

    Background:

    • Cerebral glucose utilization is a key indicator of brain function.
    • Computed tomography (CT) primarily provides structural information, limiting functional assessment.
    • Positron emission tomography (PET) offers a method to map metabolic activity.

    Purpose of the Study:

    • To investigate the utility of 18F-fluorodeoxyglucose (FDG) PET in mapping local cerebral glucose utilization.
    • To compare functional information from FDG-PET with structural data from CT.
    • To explore the diagnostic potential of FDG-PET in various neurological and psychiatric conditions.

    Main Methods:

    • Utilized 18F-fluorodeoxyglucose (FDG) PET scans to measure local cerebral glucose metabolism.
    • Studied normal volunteers to assess metabolic responses to sensory stimulation and aging.

    Related Experiment Videos

  • Applied FDG-PET to patients with stroke, depression, Alzheimer disease, Huntington disease, and partial epilepsy.

    • Main Results:

    • FDG-PET revealed more extensive brain dysfunction after stroke than CT suggested.
    • Distinct metabolic patterns were observed in depressed, demented elderly patients, Alzheimer's, and Huntington's disease.
    • FDG-PET identified hypometabolic seizure onset zones in epilepsy, often normal on CT.

    Conclusions:

    • FDG-PET provides crucial functional insights into cerebral metabolism, complementing structural imaging.
    • This technique demonstrates significant diagnostic value across a spectrum of neurological disorders.
    • FDG-PET holds promise for early detection and characterization of brain dysfunction.